Product Name: Testover P
Active substance: Testosterone Propionate
Androgenic agent also has anabolic effects. As target cells (skin, prostate, seminal vesicles) recovering the 5-alpha-reductase to 5a-dihydrotestosterone, which interacts specifically with receptors on the cell surface and into the nucleus. In some tissues (including the hypothalamus) is converted to estradiol. In men, excites the development and activity of the gonads, prostate, seminal vesicles, the formation of secondary male characteristics (height, deep voice, facial hair growth), increases libido and potency, indirectly, through the central nervous system, affects sexual behavior. Reduces fat accumulation and excretion of trace elements. Suppresses the production and release of pituitary LH and FSH. Has anabolic effects: involved in skeletal growth and increases skeletal muscle mass, causes a delay of nitrogen, phosphorus, K +, sulfur needed for protein synthesis.
Men: replacement therapy for primary and secondary hypogonadism (delayed puberty, hypopituitarism, post-castration syndrome, oligospermia) male menopause, impotence (impotentia generandi virilis), male infertility (in violation of spermatogenesis), androgen deficiency, osteoporosis due to lack of androgens. In women, breast cancer, Hyperestrogenism dysfunctional bleeding, uterine fibroids, endometriosis, climacteric disorders in women (with estrogens), premenstrual syndrome, breast cancer (metastatic later), osteoporosis.
Contraindications and Cautions:
Hypersensitivity, prostate cancer and / or breast cancer, gynecomastia, nephrosis or nephrotic stage nephritis, prostatic hypertrophy with urinary maintenance, liver / kidney failure, hypercalcemia, edema, heart failure, diabetes mellitus, history of myocardial infarction, commonly atherosclerosis, pregnancy, lactation. Asthenic physique, mature men, teens boys (before puberty).
Acne, seborrhea, swelling, allergic reactions, increased libido, frequent erections, decreased volume of ejaculate, hypercalcemia, impaired spermatogenesis and sperm maturation, priapism, precocious puberty boys, the increase in the size of the penis, premature closure of the epiphyseal bone, the delay Na + and water, dizziness, nausea, pain, itching, redness at the injection site, bleeding from the gastrointestinal tract, metrorrhagia, thrombophlebitis, cholestatic jaundice, increased activity of "liver" enzymes. With prolonged use in women - virilization syndrome (deepening of the voice, excessive hair growth on the face or body), atrophy of the mammary glands, amenorrhea.
Men with eunuchoidism, congenital hypoplasia gonads, their removal by surgery or by trauma, as well as acromegaly - 25 mg daily, or 50 mg every 1-2 days, or 100-200 mg (1-2 ml 10 % solution), one every 15 days. Duration of treatment depends on the effectiveness of treatment and the nature of the disease. After the perfection of clinical use maintenance doses - 5.10 mg daily or every other day, or to the reception inside methyltestosterone. When functional impotence against gonadal failure, fatigue and nervous exhaustion, as well as male climacteric syndrome - 10 mg daily or 25 mg 2-3 times a week for 1-2 months. In prostatic hypertrophy in the initial stage of 10 mg administered a day for 1-2 months.
Women over 45 years old with dysfunctional uterine hemorrhage - at 10-25 mg a day for 20-30 days. You must first eliminate malignant tumors of the uterus. In vascular and neurological disorders of climacteric origin women and contraindications to the use of estrogen - 10 mg a day or 100 mg 1 time per week for 2-3 weeks. In malignant tumors of the breast or ovaries - 50 mg daily or 100 mg for a few months, then depending on the outcome of the treatment dose and reduce long-term supporting doses (100-200 mg every 1-2 weeks).
With the instantaneous use with inducers of microsomal oxidation, enzymes (barbiturates, rifampicin, etc.) may decrease the efficacy of testosterone.
Store in a dry place protected from light, at a temperature of 15-25 ° C. Keep out of the reach and sight of kids.